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Separation of betaxolol, bevantolol, metoprolol, bisoprolol with new bonded chiral stationary (3,5-dimethylcabamate cellulose) 
Chiralpak IB column was investigated. The factors, such as mobile phase composition and the ratio, column temperature, flow 
rate and the proportion of chiral additives, were also investigated. The optimal mobile phase compositions of betaxolol, bevantolol, 
metoprolol, bisoprolol were n-hexane/ethanol (95/5, v/v; 0.2% DEA); n-hexane/ethanol (90/10, v/v; 0.1% DEA); hexane/ethanol 
(60/40, v/v; 0.1% DEA); n-hexane/ethanol (95/5, v/v; 0.2% DEA), respectively. The optimal temperature was 30°C with a flow 
rate of 0.8 mL min1. The detection wavelength, by 1200VWD UV detector, of betaxolol, bevantolol, metoprolol, bisoprolol was 
259, 274, 224 and 223 nm, respectively. Experimental results demonstrated that baseline separation (Rs>1.5) of the betaxolol, 
bevantolol, metoprolol, bisoprolol enantiomers were obtained with new bonded Chiralpak IB column. This method can be used 
for analysis and detection of these four drugs. 
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-Receptor blockers are widely used in clinical treatment [1] 
of angina pectoris, arrhythmia, hypertension, myocardial 
infarction and other heart diseases, as well as hypertrophic 
heart disease, pheochromocytoma, hyperthyroidism, migraine 
and glaucoma. The drugs contain 1 or 2 asymmetric carbon 
atoms. Structure of betaxolol, bevantolol, metoprolol, bi-
soprolol is shown in Figure 1. 
This study on separation methods of -lol drugs enantio-
mers is of great significance to the stereo selectivity differ-
ences between their dynamics and pharmacokinetics. A few 
of chromatographic methods for the separation of -lol drugs 
enantiomers have been reported, such as High Performance 
Capillary Electrophoresis (HPCE) [2,3], Capillary Electro-
chromatography (CE) [4], High Performance Liquid Chro-
matography (HPLC) [5–9], etc. According to the literature, 
by lipase catalyzed -amino alcohol, Yang and Chen [10] 
gets S-betaxolol and R-betaxolol enantiomers. By chiral 
derivatizating RP column, Darmon et al. [11] separated 
betaxolol successfully. By Chiralcel OD column, Krstulovic 
et al. [12] separated betaxolol directly and successfully. By 
Chiralcel OD column, Ekelund et al. [13] successfully sepa-
rated betaxolol and bevantolol, metoprolol, bisoprolol as 
well. 
The chiral stationary phase of Chiralpak IB column [14] 
was 3,5-dimethyl carbamate polysaccharide cellulose deriv-
atives bonded silica gel. Compared to the coated stationary 
phase, bonded ones expanded the use of the mobile phase, 
and the performance of HPLC was also improved. Besides, 
it can be used not only in the normal phase column, but also 
in the RP system. Experiments showed that bonded Chi-
ralpak IB column worked effectively and it had advantages 
in separating chiral drugs.  
Literatures about the use of bonded Chiralpak IB col-
umns in betaxolol, bevantolol, metoprolol, bisoprolol have 
not been found. This article was about chiral separation of 
the above 4 -lol drugs. The factors, such as mobile phase  
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Figure 1  Molecule structure of four -blockers.  
composition and the ratio, column temperature, flow rate 
and the proportion of chiral modifier diethyl amine, were 
also investigated. 
1  Experimental 
1.1  Reagents 
Betaxolol hydrochloride was obtained from Zhengzhou 
University New Drugs Research and Development Center, 
the content of which was 99.6%, determined by USP24 
method. Metoprolol tartrate was obtained from Weikang 
(China). Bevantolol hydrochloride was obtained from J&N 
Chuangyi (China). Bisoprolol fumarate was obtained from 
B&J Fengde (China), the purity of which was 99%. HPLC- 
grade n-hexane, absolute ethyl ethanol, isopropanol and 
methanol were chromatographic pure, and diethylamine 
(DEA) was analytical pure (T&J Kermel Reagent). 
1.2  Apparatus 
The chromatograph system consisted of an Agilent HP1100 
HPLC apparatus, a 1200VWD UV detector, a 1200 manual 
sample injector, HP chemistry workstation. The HPLC col-
umn was a Chialpak IB (250 mm × 4.6 mm, 5 m) (Japan). 
Ultra pure water was obtained by Millipore system (USA). 
The size of balance was BP211D1/100 thousand (Sartorius, 
Germany). KQ3200DE numerical control ultrasound clean-
ing apparatus was from K&S Ultrasound Apparatus Cor. 
The size of millipore filter (mix cellulose membrane) was 
0.25 m (S&H Xinya, China). 
1.3  Chromatographic condition 
The base solvent of mobile phase was n-hexane, with the 
polarity modifier was isopropanol or ethanol and the mobile 
phase additive was DEA. Mobile phase were filtered with 
0.45 m solvent filter and ultrasonically degassed. The UV 
detecting wavelength of betaxolol, bevantolol, metoprolol, 
bisoprolol was 259, 274, 224 and 223 nm, respectively. The 
column temperature was 30°C with a flow rate of 0.8    
mL min1, and the sampling volume was 20 L. 
1.4  Sample preparation  
The 1.0 mg of chiral bulk drug was dissolved in 5 mL etha-
nol and then filtered (0.45 m). 
2  Results and discussion 
The type and constitute of mobile phase, the content of al-
kalinity additive, the column temperature and the flow rate 
of 4 -lol drugs were investigated, hoping to get optimal re-
tention time and resolution. 
2.1  Effect of ethanol content on the enantioselectivity 
of the 4 -lol drugs 
With the flow rate of 0.8 mL min1 and the column temper-
ature at 25°C, the content of ethanol was investigated. Table 
1 summarizes their retention time (tR1, tR2) for the first and 
second eluted enantiomers, retention factors (k′1, k′2) for the 
first and second eluted enantiomers, separation factors () 
and resolution factors (Rs). 
The results showed that with the reduction of the propor-
tion of ethanol, 4 -lol drugs enantiomers peak time was ex-
tended, however the resolution was increased. This showed 
that with the decreasing of ethanol ratio, the force between 
enantiomers and mobile phase reduced, leading to the in-
creasing of the retention time, so the peak time extended, 
and at the same time increasing the opportunity that the en-
antiomers affected chiral stationary phase. 
But with the increasing of hexane ratio, most of the -lol 
drugs did not reach the baseline separation. At this point, 
basic regulator DEA can be added to improve the peak shape. 
2.2  Effect of isopropanol content on the  
enantioselectivity of the 4 -lol drugs 
With flow rate of 0.8 mL min1 and at 25°C column  
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Table 1  Effect of content of ethanol on the enantioselectivity of the 4 -lol drugsa) 
Drugs n-hexane/ethanol tR1 (min) tR2 (min) k′1 k′2  RS 
Betaxolol 99:1 44.3 49.2 22.7 25.3 1.1 0.71 
 95:5 28.3 31.1 14.2 15.6 1.1 0.63 
 90:10 14.5 15.9 6.8 7.5 1.1 0.58 
 80:20 9.1 9.8 3.9 4.3 1.1 0.52 
 70:30 8.3 8.9 1.4 3.6 2.6 0.41 
 60:40 7.3 2.9   
Metoprolol 99:1 40.5 47.2 20.1 24.2 1.2 2.91 
 95:5 18.2 20.2 8.7 9.8 1.1 1.66 
 90:10 11.5 12.8 5.1 5.8 1.1 1.56 
 80:20 7.9 8.6 3.2 3.6 1.1 1.12 
 70:30 6.5 7.1 2.5 2.8 1.1 0.82 
 60:40 5.3 6.2 1.8 2.3 1.3 0.63 
Bevantolol 95/5 >100    
 90:10 >100    
 80:20 36.3 55.7 18.4 28.8 1.6 8.4 
 70:30 18.7 28.7 8.9 14.3 5.0 7.4 
 60:40 7.4 13.6 3.0 6.3 2.1 2.6 
Bisoprolol 99:1 46.2 68.8 23.7 35.8 1.5 0.87 
 95:5 28.5 30.6 14.2 15.4 1.1 0.50 
 90:10 19.0 19.9 9.2 9.6 1.0 0.44 
 80:20 10.0 10.4 4.3 4.6 1.1 0.41 
 70:30 8.4 8.6 3.5 3.6 1.0 0.37 
 60:40 7.5 3.0   
a) Chromatographic condition: Column temperature was at 25°C. Flow rate was 0.8 mL min1. “” means that retention time was too long or did not ob-
serve the separation. “>100” means that retention time was over 100 min. If there is only one numerical value in tR or k′, it means that the enantiomers were 
not separated at all.  
temperature, the content of polarity regulator isopropanol 
was investigated. The separation data of betaxolol, bevanto-
lol, metoprolol, bisoprolol are shown in Table 2. 
The results showed that when the isopropanol ratio was 
reduced, the peak time extended, this should be conducive 
to the separation of enantiomers. But except that bevantolol 
was separated when the ratio of isopropanol was 40%, the other 
three -lol drugs did not get baseline separation at all. While 
the peak time extended, eddy diffusion and vertical diffu-
sion will be caused, impacting peak shape at the same time.  
In fact, it was not suitable to use isopropanol as mobile 
phase modifiers to separate the four types of drug enantio-
mers. In contrast with considering hexane-ethanol as the 
mobile phase, the hexane-ethanol system was taken. 
Table 2  Effect of content of isopropanol on the enantioselectivity of the 4 -lol drugsa) 
Drugs n-hexane/isopropanol tR1 (min) tR2 (min) k′1 k′2  RS 
Betaxolol 80:20 >60    
 70:30 >60    
 60:40 39.5 20.1   
      
Metoprolol 80:20 62.5 32.4   
 70:30 35.8 20.7   
 60:40 19.1 10.2   
      
Bevantolol 80:20 >100    
 70:30 >100    
 60:40 21.4 54.3 10.4 28.0 2.7 4.6 
Bisoprolol 80:20 >100    
 70:30 43.2 22.1   
 60:40 28.8 14.4   
a) Chromatographic condition: Column temperature was at 25°C. Flow rate was 0.8 mL min1. “” means that retention time was too long or did not ob-
serve the separation. “>100” means that retention time was over 100 min. If there is only one numerical value in tR or k′, it means that the enantiomers were 
not separated at all.  
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2.3  Effect of DEA on the enantioselectivity of the 4 -lol 
drugs  
When selected polarity regulator, neither ethanol nor iso-
propanol could well separate the 4 -lol drugs. In view of this, 
DEA was taken as the suppressing reagent, hoping to im-
prove the shape of peak. Experiments were carried out to 
investigate the effect of the content of additive DEA on the 
enantioselectivity of the 4 -lol drugs. The separation data of 
betaxolol, metoprolol, bevantolol, bisoprolol in mobile 
phase with different proportion of DEA are listed in Table 3. 
The results showed that four drugs were baseline sepa-
rated and peak shapes were fine. With the increase of the 
content of DEA, 4 -lol drug enantiomers were separated 
earlier and its resolution also increased. But when the DEA 
concentration increased to a certain value, the resolution 
will appear extreme and then reduce. This showed that by 
adding DEA to the mobile phase, the separation appeared 
better. This may be due to the fact that the 4 drugs all con-
tain kinds of drugs polar groups such as –NH2 and –OH. 
Without DEA, they can form hydrogen bonding with –CO 
or –NH2 in the chiral stationary phase. This increased the 
retention time that alcohol amine drug enantiomers stay in 
the column so that even if ethanol or isopropanol was added 
to the mobile phase, they cannot be washed off. When add-
ing DEA, the polarity increased, helping drug molecules 
elute from the stationary phase. What’s more, with DEA, 
alkaline environment was obtained, and drugs existenced as 
molecular form. Thus the selectivity of stationary phase was 
improved. With the increase of DEA content, the separation 
capacity improved. When it continued to increase, due to 
the decrease of retention, the resolution decreased as well.  
2.4  Effect of column temperature on the  
enantioselectivity of the 4 -lol drugs 
On the basis of baseline separation, we selected the best 
separation conditions except the column temperature. By 
changing column temperature, we studied the impact of 
column temperature on separation of drugs. The separation 
data of betaxolol, bevantolol, metoprolol, bisoprolol in dif-
ferent column temperatures are listed in Table 4. 
The experimental results showed that in this mobile phase 
system, separation factor and resolution of the enantiomers  
Table 3  Effect of content of DEA on the enantioselectivity of the 4 -lol drugsa) 
Drugs DEA (%) tR1 (min) tR2 (min) k′1 k′2  RS 
Betaxolol 0.1 11.5 14.7 5.2 6.8 1.3 4.39 
 0.2 10.4 13.5 4.6 6.2 1.4 5.19 
 0.3 9.6 12.6 4.1 5.7 1.4 4.88 
 0.4 9.5 12.6 4.1 5.7 1.4 5.00 
 0.5 43.2 12.3 3.9 5.6 1.4 1.43 
        
Metoprolol 0.1 8.7 10.3 3.7 4.5 1.2 2.95 
 0.2 8.0 9.3 3.3 4.0 1.2 2.97 
 0.3 7.6 9.2 3.1 3.9 1.3 2.99 
 0.4 7.2 8.7 2.9 3.7 1.3 2.46 
 0.5 7.1 8.6 2.8 3.6 1.3 2.39 
        
Bevantolol 0.1 6.5 13.0 2.5 6.0 2.4 13.4 
 0.2 6.5 12.8 2.5 5.8 2.3 13.3 
 0.3 6.3 12.4 2.4 5.6 2.3 13.3 
 0.4 6.3 12.2 2.4 5.5 2.3 13.3 
 0.5 6.1 11.2 2.3 5.0 2.2 11.9 
        
Bisoprolol 0.1 12.8 14.7 5.8 6.9 1.19 2.38 
 0.2 12.3 14.3 5.6 6.6 1.18 2.49 
 0.3 11.4 13.5 5.1 6.2 1.22 2.96 
 0.4 11.4 13.4 5.1 6.2 1.22 2.55 
 0.5 11.1 13.2 5.0 6.1 1.22 2.42 
a) Chromatographic condition: Column temperature was at 25°C. Flow rate was 0.8 mL min1. Mobile phase: betaxolol: n-hexane/absolute ethanol (95/5, 
v/v), metoprolol: n-hexane/absolute ethanol (95/5, v/v), bevantolol: n-hexane/absolute ethanol (60/40, v/v), bisoprolol: n-hexane/absolute ethanol (95/5, v/v).  
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Table 4  Effect of temperature on the enantioselectivity of the 4 -lol drugsa) 
Drugs T(°C) tR1 (min) tR2 (min) k′1 k′2  RS 
Betaxolol 20 10.6 14.0 4.7 6.5 1.4 5.01 
 25 10.4 13.5 4.6 6.2 1.4 5.19 
 30 10.1 13.1 4.4 6.0 1.4 5.26 
Metoprolol 20 9.0 10.7 3.8 4.7 1.2 3.07 
 25 8.7 10.3 3.7 4.5 1.2 3.08 
 30 8.6 10.2 3.6 4.4 1.2 3.17 
Bevantolol 20 6.6 13.3 2.6 6.1 2.4 12.2 
 25 6.5 13.0 2.5 6.0 2.4 13.2 
 30 6.5 12.6 2.5 5.8 2.3 13.3 
Bisoprolol 20 12.7 14.8 5.8 7.0 1.2 2.46 
 25 12.3 14.3 5.6 6.6 1.2 2.49 
 30 12.2 14.0 5.5 6.5 1.2 2.50 
a) Chromatographic condition: Flow rate was at 0.8 mL min1. Mobile phase: betaxolol: n-hexane/absolute ethanol (95/5, v/v; 0.1% DEA); metoprolol: 
n-hexane/absolute ethanol (95/5, v/v; 0.1% DEA); bevantolol: n-hexane/absolute ethanol (60/40, v/v; 0.1% DEA); bisoprolol: n-hexane/absolute ethanol 
(95/5, v/v; 0.1% DEA).  
reduced with the increase of column temperature. 
The relationship between solute capacity factor and the 
temperature can be expressed by the following equation:  
 0 0R,S R,Sln ,H RT S R        (1) 
where R,SH0, R,SS0 were the difference of enthalpy and 
entropy of two enantiomers from the mobile phase to the 
stationary phase during the distribution process, respectively. 
With lnα for the vertical axis Y, 1/T abscissa X, Y on X 
mapping, as shown in Figure 2. The results showed that the 
linear of the regression equations was perfect. Over the 
temperature ranges of 293–303 K, |R,SH0|>|T·R,SS0, as 
shown in Table 5. So the conclusion that the chiral separation 
process is controlled by enthalpy can be obtained. 
 
Figure 2  ln-1/T scatters of 4 -lol drugs.  
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Table 5  Thermodynamic parameters of the 4 drugs 
Drugs R,SH0 R,SS0 R 
Betaxolol 168.2 0.2912 0.8686 
Metoprolol 143.2 0.2746 0.9999 
Bevantolol 305.6 0.2385 0.9094 
Bisoprolol 5.867 0.0680 0.8635 
 
The results showed that with increasing of temperature, 
the enantiomeric separation increased, peak time appeared 
slightly earlier. When temperature is 30°C, the drugs were 
best separated. So the temperature 30°C was taken. 
2.5  Effect of flow rate on the enantioselectivity of the 4 
-lol drugs  
The separation data of betaxolol, bevantolol, metoprolol, 
bisoprolol in different flow rate are listed in Table 6. 
The Van Deemter equation is  
 ,H A B u C u     (2) 
where H is height of theoretical plate (mm), and u is the 
flow rate (cm s1). 
By the equation, the Hmin and the best flow rate were plot-
ted and calculated. The range of best flow rate was 551.9– 
1003.4 cm s1, that was 0.55–1.00 mL min1. At 0.8 mL min1, 
baseline separation can be obtained and the shapes were 
fine, so the rate of 0.8 mL min1 was taken. 
The results showed that at different flow rates, the reso-
lution of drugs was similar. By the Van Deemter chroma-
tography theory, the vertical proliferation plays a major 
role at low flow, and the mass transfer resistance plays a 
major role at a high rate. Chromatograms of the 4 -lol drugs 
under the best chromatographic conditions are shown in 
Figure 3. 
Table 6  Effect of flow rate on the enantioselectivity of the 4 -lol drugsa) 
Drugs Flow rate (mL min1) k′1 k′2  Rs HETP1 (m) HETP2 (m) 
Betaxolol 0.5 4.3 5.8 1.35 5.41 3.853 3.813 
 0.8 4.4 6.0 1.36 5.26 3.424 3.781 
 1.0 3.3 4.4 1.33 4.74 4.679 4.766 
Metoprolol 0.5 3.5 4.3 1.23 3.14 4.964 4.738 
 0.8 3.6 4.4 1.22 3.17 3.553 2.951 
 1.0 3.5 4.3 1.23 2.99 5.950 5.720 
Bevantolol 0.5 2.4 5.1 2.13 12.55 4.689 4.207 
 0.8 2.5 6.0 2.40 13.38 3.828 3.203 
 1.0 2.4 5.2 2.17 11.53 3.689 3.138 
Bisoprolol 0.5 5.3 6.3 1.19 2.92 4.884 4.524 
 0.8 5.5 6.5 1.18 2.50 5.686 5.069 
 1.0 5.4 6.3 1.17 2.48 7.196 6.438 
a) Chromatographic condition: Column temperature was 30°C. Flow rate was at 0.8 mL min1. Mobile phase: betaxolol: n-hexane/absolute ethanol (95/5, 
v/v; 0.1% DEA); metoprolol: n-hexane/absolute ethanol 95/5, v/v; 0.1% DEA); bevantolol: n-hexane/absolute ethanol (60/40 v/v; 0.1% DEA); bisoprolol: 
n-hexane/absolute ethanol (95/5, v/v; 0.1% DEA). 
 
Figure 3  HPLC chromatograms of 4 drugs on bonded Chiralpak IB column. Chromatographic condition: Column temperature was at 30°C. Flow rate was 
0.8 mL min1. Mobile phase: betaxolol: hexane/ethanol (95/5, v/v; 0.1% DEA), metoprolol (95/5, v/v; 0.1% DEA), bevantolol (60/40, v/v; 0.1% DEA), 
bisoprolol (95/5, v/v; 0.1% DEA). (a) Betaxolol hydrochloride mobile phase: hexane/ethanol (95/5, v/v; 0.2% DEA), temperature: 30°C, flow rate: 0.8 mL min1; 
(b) metoprolol tartrate mobile phase: hexane/ethanol (90/10, v/v; 0.1% DEA), temperature: 30°C, flow rate: 0.8 mL min1; (c) bevantolol hydrochloride 
mobile phase: hexane/ethanol (60/40, v/v; 0.1% DEA), temperature: 30°C, flow rate: 0.8 mL min1; (d) bisoprolol fumarate mobile phase: hexane/ethanol 
(95/5, v/v; 0.2% DEA), temperature: 30°C, flow rate: 0.8 mL min1.  
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3  Conclusions 
The enantiomers of betaxolol, metoprolol, bevantolol, bi-
soprolol were separated on column Chiralpak IB success-
fully. The experiment showed that the Chiralpak IB column 
worked effectively and had certain advantage in separating 
chiral drugs. In summary, a specific and sensitive HPLC 
method was developed for the separation of the enantiomers 
of betaxolol, metoprolol, bevantolol, bisoprolol.  
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